Trust Co. of Vermont Buys 1,114 Shares of Aetna Inc. (AET)
Trust Co. of Vermont boosted its stake in shares of Aetna Inc. (NYSE:AET) by 43.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,684 shares of the company’s stock after buying an additional 1,114 shares during the period. Trust Co. of Vermont’s holdings in Aetna were worth $559,000 as of its most recent filing with the SEC.
A number of other large investors have also recently made changes to their positions in AET. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Aetna by 31.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 52,641 shares of the company’s stock valued at $6,713,000 after buying an additional 12,648 shares during the period. Columbus Circle Investors raised its position in shares of Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock valued at $6,611,000 after buying an additional 40,535 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Aetna by 0.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 282,165 shares of the company’s stock valued at $35,990,000 after buying an additional 875 shares during the period. Toronto Dominion Bank raised its position in shares of Aetna by 57.0% in the first quarter. Toronto Dominion Bank now owns 95,608 shares of the company’s stock valued at $12,194,000 after buying an additional 34,719 shares during the period. Finally, Boston Advisors LLC raised its position in shares of Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock valued at $371,000 after buying an additional 500 shares during the period. 91.73% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (AET) traded up 0.10% during mid-day trading on Monday, hitting $156.94. 1,107,578 shares of the stock were exchanged. The stock has a market cap of $52.06 billion, a PE ratio of 47.86 and a beta of 0.54. The stock’s 50 day moving average is $153.22 and its 200-day moving average is $137.42. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $157.79.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the prior year, the company posted $2.21 earnings per share. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, analysts anticipate that Aetna Inc. will post $9.38 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.27%. Aetna’s dividend payout ratio (DPR) is currently 43.67%.
Several research analysts have commented on the stock. Deutsche Bank AG upped their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday. Jefferies Group LLC restated a “hold” rating and issued a $163.00 price objective on shares of Aetna in a report on Friday. Royal Bank Of Canada upped their price objective on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday. BidaskClub lowered shares of Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Finally, Credit Suisse Group restated an “outperform” rating and issued a $165.00 price objective (up from $160.00) on shares of Aetna in a report on Thursday, July 13th. Eight analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $155.78.
In related news, Chairman Mark T. Bertolini sold 103,547 shares of the company’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the sale, the chairman now owns 659,888 shares in the company, valued at $92,905,631.52. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.